Own brand products underpin revenue growth at Advanced Medical Solutions

AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct.

AIM-listed Advanced Medical Solutions reported that group revenue rose 53 per cent to 52.6m pounds in the year ended December 31st, supported by strong performance in its own brand business, Branded Direct.

Within the Branded Direct business, ActivHeal brand achieved a 29% increase in revenues, LiquiBand in the UK grew by 5.0% and direct sales of RESORBA's sutures, collagen and dental products into the German domestic market grew by 5.0% compared with 2011. Advanced Medical Solutions acquired RESORBA in December 2011.

Adjusted profit before tax was up 85% at the group to £12.1m and adjusted fully diluted earnings per share were up 24% to 5.30p. Reported fully diluted earnings per share were up 53% to 4.66p.

Chairman announces he will step downDr Don Evans announced his intention to step down as Chairman later in the year after more than a decade and a half with the group.

"In my 16 years with AMS I have seen the complete transformation of the group, and I know that I will be leaving a business in excellent shape for future growth," Evans said.

Commenting on the financial results Evans, said: "2012 was an important year for AMS following the acquisition of RESORBA in late December 2011.

"Group revenues and profits both saw strong growth as a result, not just from the new business we acquired but also from many of our existing operations which continued the excellent progress of the last few years.

"With the group now reorganised and more focused to deliver growth across our four new business units, we remain positive about our prospects."

Advanced Medical Solutions develops and manufactures advanced wound care dressing technologies for the management of chronic and acute wounds.

The group's share price was up 6.82% to 70.50p at 09:58 on Wednesday.

MF

Recommended

Broker safety – your questions answered
Investment strategy

Broker safety – your questions answered

Cris Sholto Heaton answers more of your questions about the safety of stockbroker accounts
25 Mar 2020
How demographics affects stock valuations
Investment strategy

How demographics affects stock valuations

New research suggests that stock and bond valuations are driven by the age of the population – at least in the US.
24 Feb 2020
Do you own shares in Sirius Minerals? Here’s what you need to do now
Stocks and shares

Do you own shares in Sirius Minerals? Here’s what you need to do now

Mining giant Anglo American has proposed a cash takeover of Yorkshire-based minnow Sirius Minerals. Unhappy shareholders must decide whether to accept…
20 Feb 2020
Why investors should be “cautiously bullish” for 2020
Stockmarkets

Why investors should be “cautiously bullish” for 2020

Analysts have been out in force making rosy predictions for stockmarkets in 2020, but while there is certainly a case for optimism, investors should r…
17 Jan 2020

Most Popular

Will a second wave of Covid lead to another stockmarket crash?
Stockmarkets

Will a second wave of Covid lead to another stockmarket crash?

Can we expect to see another lockdown like in March, and what will that mean for your money? John Stepek explains.
18 Sep 2020
Here’s why you really should own at least some bitcoin
Bitcoin

Here’s why you really should own at least some bitcoin

While bitcoin is having a quiet year – at least in relative terms – its potential to become the default cash system for the internet is undiminished, …
16 Sep 2020
James Ferguson: How bad data is driving fear of a second wave of Covid-19
UK Economy

James Ferguson: How bad data is driving fear of a second wave of Covid-19

Merryn and John talk to MoneyWeek regular James Ferguson about the rise in infections in coronavirus and what the data is really telling us.
17 Sep 2020